Cargando…

A multicomponent intranasal adjuvant drives durable humoral, cellular, and mucosal immune responses to SARS-CoV-2 in young and aged mice

Multiple FDA-approved SARS-CoV-2 vaccines provide excellent protection against severe disease. Despite this, immunity can wane relatively fast, particularly in the elderly and novel viral variants capable of evading infection- and vaccination-induced immunity continue to emerge. Intranasal (IN) vacc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jangra, Sonia, Landers, Jeffrey J., Laghlali, Gabriel, Rathnasinghe, Raveen, O’Konek, Jessica. J., Janczak, Katarzyna W., García-Sastre, Adolfo, Baker, James R., Schotsaert, Michael, Wong, Pamela T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Journal Experts 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9882683/ https://www.ncbi.nlm.nih.gov/pubmed/36711479 http://dx.doi.org/10.21203/rs.3.rs-2457013/v1

Ejemplares similares

Multicomponent intranasal adjuvant for mucosal and durable systemic SARS-CoV-2 immunity in young and aged mice
por: Jangra, Sonia, et al.
Publicado: (2023)

A Combination Adjuvant for the Induction of Potent Antiviral Immune Responses for a Recombinant SARS-CoV-2 Protein Vaccine
por: Jangra, Sonia, et al.
Publicado: (2021)

RIG-I and TLR-7/8 agonists as combination adjuvant shapes unique antibody and cellular vaccine responses to seasonal influenza vaccine
por: Jangra, Sonia, et al.
Publicado: (2022)

Immunomodulation of T(H)2 biased immunity with mucosal administration of nanoemulsion adjuvant
por: Bielinska, Anna U., et al.
Publicado: (2016)

The virucidal effects of 405 nm visible light on SARS-CoV-2 and influenza A virus
por: Rathnasinghe, Raveen, et al.
Publicado: (2021)

Mucosal Nanoemulsion Allergy Vaccine Suppresses Alarmin Expression and Induces Bystander Suppression of Reactivity to Multiple Food Allergens
por: Farazuddin, Mohammad, et al.
Publicado: (2021)

SARS-CoV-2 spike E484K mutation reduces antibody neutralisation
por: Jangra, Sonia, et al.
Publicado: (2021)

The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera.
por: Jangra, Sonia, et al.
Publicado: (2021)

The unfulfilled potential of mucosal immunization
por: Baker, James R., et al.
Publicado: (2022)

Prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine.
por: Rathnasinghe, Raveen, et al.
Publicado: (2021)

Interferon mediated prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine lacking non-structural protein 1
por: Rathnasinghe, Raveen, et al.
Publicado: (2021)

Formulation, High Throughput In Vitro Screening and In Vivo Functional Characterization of Nanoemulsion-Based Intranasal Vaccine Adjuvants
por: Wong, Pamela T., et al.
Publicado: (2015)

Introduction of two prolines and removal of the polybasic cleavage site leads to optimal efficacy of a recombinant spike based SARS-CoV-2 vaccine in the mouse model
por: Amanat, Fatima, et al.
Publicado: (2020)

Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model
por: Amanat, Fatima, et al.
Publicado: (2021)

Nanoemulsion Adjuvant Augments Retinaldehyde Dehydrogenase Activity in Dendritic Cells via MyD88 Pathway
por: Farazuddin, Mohammad, et al.
Publicado: (2019)

Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Modified Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine
por: Jangra, Sonia, et al.
Publicado: (2020)

Replication-Competent ΔNS1 Influenza A Viruses Expressing Reporter Genes
por: Nogales, Aitor, et al.
Publicado: (2021)

Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection
por: Rathnasinghe, Raveen, et al.
Publicado: (2020)

Intranasal immunization with W(80)5EC adjuvanted recombinant RSV rF-ptn enhances clearance of respiratory syncytial virus in a mouse model
por: Passmore, Crystal, et al.
Publicado: (2014)

Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection
por: Rathnasinghe, Raveen, et al.
Publicado: (2020)

Scalable, effective, and rapid decontamination of SARS-CoV-2 contaminated N95 respirators using germicidal ultraviolet C (UVC) irradiation device
por: Rathnasinghe, Raveen, et al.
Publicado: (2021)

Influenza breakthrough infection in vaccinated mice is characterized by non-pathological lung eosinophilia
por: Chang, Lauren A., et al.
Publicado: (2023)

Retinoic Acid Signaling Is Required for Dendritic Cell Maturation and the Induction of T Cell Immunity
por: Farazuddin, Mohammad, et al.
Publicado: (2023)

Intranasal SARS-CoV-2 spike-based immunisation adjuvanted with polyethyleneimine elicits mucosal and systemic humoral responses in mice
por: Deimel, Lachlan P., et al.
Publicado: (2022)

Characterization of Systemic and Mucosal Humoral Immune Responses to an Adjuvanted Intranasal SARS-CoV-2 Protein Subunit Vaccine Candidate in Mice
por: Maltseva, Mariam, et al.
Publicado: (2022)

Masked Delivery of Allergen in Nanoparticles Safely Attenuates Anaphylactic Response in Murine Models of Peanut Allergy
por: Hughes, Kevin R., et al.
Publicado: (2022)

Editorial: Food allergy: advances in basic and translational animal models
por: Dolence, Joseph J., et al.
Publicado: (2023)

Intranasal Vaccination with Murabutide Enhances Humoral and Mucosal Immune Responses to a Virus-Like Particle Vaccine
por: Jackson, Erin M., et al.
Publicado: (2012)

Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses
por: Hasegawa, Hideki, et al.
Publicado: (2009)

Suitability of Polymyxin B as a Mucosal Adjuvant for Intranasal Influenza and COVID-19 Vaccines
por: Yoshino, Naoto, et al.
Publicado: (2023)

Unrepairable DNA Double Strand Breaks Initiate Cytotoxicity with HSV-TK/Ganciclovir
por: Ladd, Brendon, et al.
Publicado: (2011)

Polymyxins as Novel and Safe Mucosal Adjuvants to Induce Humoral Immune Responses in Mice
por: Yoshino, Naoto, et al.
Publicado: (2013)

Non-sterilizing, Infection-Permissive Vaccination With Inactivated Influenza Virus Vaccine Reshapes Subsequent Virus Infection-Induced Protective Heterosubtypic Immunity From Cellular to Humoral Cross-Reactive Immune Responses
por: Choi, Angela, et al.
Publicado: (2020)

Influenza Vaccines: A Moving Interdisciplinary Field
por: Schotsaert, Michael, et al.
Publicado: (2014)

Unpolarized Release of Vaccinia Virus and HIV Antigen by Colchicine Treatment Enhances Intranasal HIV Antigen Expression and Mucosal Humoral Responses
por: Zhang, Yan, et al.
Publicado: (2011)

The intranasal adjuvant Endocine™ enhances both systemic and mucosal immune responses in aged mice immunized with influenza antigen
por: Falkeborn, Tina, et al.
Publicado: (2017)

Nano-Encapsulated Melatonin: A Promising Mucosal Adjuvant in Intranasal Immunization against Chronic Experimental T. gondii Infection
por: Said, Doaa E., et al.
Publicado: (2022)

Host immune response–inspired development of the influenza vaccine
por: Choi, Angela, et al.
Publicado: (2020)

Cytokines: The Future of Intranasal Vaccine Adjuvants
por: Thompson, Afton L., et al.
Publicado: (2011)

MLH1 Deficiency Enhances Tumor Cell Sensitivity to Ganciclovir
por: O’Konek, Jessica J., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_amj4ql9f3gi0k3buu84j4gi6cc